Skip to main content
. 2020 Apr 28;38(19):2160–2169. doi: 10.1200/JCO.20.00203

FIG 3.

FIG 3.

Association of dintuximab (DIN) trough level and response in patients with an available plasma sample on day 1 of cycle 2. Relationship between response (complete response [CR]/partial response [PR]; n = 20 v stable disease [SD]/progressive disease [PD]; n = 21) and median DIN level (ng/mL) measured on day 1 of cycle 2. P value calculated using the Mann-Whitney-Wilcoxon test (P < .001). Data for 40 patients are shown. One responder had a DIN level of 12,595 ng/mL (off the scale for this figure). Values for all 41 patients were included in statistical analyses.